Notice of Injunction Prohibiting Hytera From Selling or Distributing Any Products Containing Two-Way Radio Technology
Notice of Injunction Prohibiting Hytera From Selling or Distributing Any Products Containing Two-Way Radio Technology
The U.S. District Court for the Northern District of Illinois has temporarily enjoined Hytera Communications Corp., Ltd., from sales and distributing only Two-Way Radio Products anywhere in the world, pending Hytera’s full compliance with the U.S. Court’s anti-suit injunction orders.
Hytera respects the U.S. Court’s decision and is working to achieve full compliance with the U.S. Court’s anti-suit injunction orders.
Pursuant to the U.S. Court’s order, Hytera has broadly issued the following statement:
Please be advised the United States District Court for the Northern District of Illinois has entered an Order, effective immediately, that prohibits Hytera Communications Corporation, Ltd. (“Hytera”) and all of its officers, agents, servants, employees, affiliates, subsidiaries, and distributors and resellers of any type, and all of those persons in active concert or participation with any of them, from selling or distributing any products containing two-way radio technology anywhere in the world until further notice. Two-way radio products include portables, mobiles, base stations, and repeaters that implement two-way communication protocols, including but not limited to DMR, TETRA, and cellular protocols.
You are receiving this notice because Hytera is required to notify all of its agents, distributors, resellers, customers, and prospective customers that it is prohibited from conducting the activities set forth above.
A link to the injunction order is available here.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240407988634/en/
-
5 Undervalued Stocks to Buy to Play a Little Defense
-
Markets Brief: AI Leaders Excel In Earnings Season So Far
-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
Going Into Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
-
What’s the Difference Between the CPI and PCE Indexes?
-
After Earnings, Is Tesla Stock a Buy, a Sell, or Fairly Valued?
-
After Earnings, Is GE Aerospace Stock a Buy, a Sell, or Fairly Valued?
-
3 Good Stocks to Buy with Your Tax Refund in 2024 (Or with Any Extra Money)
-
SoFi Earnings: Revenue Growth Slows on Lower Loan Growth and Higher Credit Costs
-
Tesla: Full Self-Driving Approval In China Supports Our View for Deliveries Growth In 2024
-
Philips Earnings: Firm Reaches $1.1 Billion Settlement Agreement
-
AbbVie Earnings: Next-Generation Immunology Drugs Help Offset Humira Biosimilar Pressure
-
Exxon Earnings: Ignore Earnings Shortfall as Long-Term Growth and Improvement on Track